Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Small interfering RNA (siRNA) is a form of genetic medicine that can silence or knock out any overexpressed genes in disease.It's also called short interfering RNA.These rnas are widely used to assess the specific contributions of genes to a variety of cell phenotypes, including apoptosis, pancreatic bird signaling, cytokinesis, and cell differentiation.They are used to identify novel pathways and have a meaningful impact on the identification of targets for several diseases (such as AIDS, cancer and hepatitis) and cellular processes.The mechanism of action of siRNA involves introducing it into cells.SiRNA sequences should be designed to match the short regions of the target gene.Small interfering rnas are processed by the cell's own enzymes to eliminate the mRNA of the target gene, thereby preventing overexpression of the pathogenic gene.It is based on the natural response of cells when they detect genetic abnormalities or infections.It has some advantages over the different types of therapies currently available, such as target specificity, reduced secondary effects, and high specificity.The preclinical development duration of small interfering RNA compounds (about 15 to 24 months) is shorter than that of monoclonal antibodies (about 27 to 50 months) or other traditional small molecules (about 42 to 66 months).The shortening of preclinical stage is attributed to the rational design of RNA.The design includes mathematical algorithms assembled in software to select the most appropriate RNA sequence to silence specific genetic targets.They are usually more effective than other traditional medicines.SiRNA therapy includes liposome-based systemic therapy and nanoparticle based systemic therapy.Liposome-based systems are associated with liver-targeted pharmacokinetics, which limits the therapeutic potential of siRNA therapy to other common liver diseases, such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia.
The report details the trend, potential and market size of Small Interfering RNA (siRNA) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Small Interfering RNA (siRNA) Therapeuticsmarket, defines the market attractiveness level of Small Interfering RNA (siRNA) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Small Interfering RNA (siRNA) Therapeutics industry, describes the types of Small Interfering RNA (siRNA) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Small Interfering RNA (siRNA) Therapeutics market and the development prospects and opportunities of Small Interfering RNA (siRNA) Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Small Interfering RNA (siRNA) Therapeutics market in Chapter 13.
By Player:
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
By Type:
Type 1
Type 2
Type 3
By End-User:
Application 1
Application 2
Application 3
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Small Interfering RNA (siRNA) Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Small Interfering RNA (siRNA) Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Small Interfering RNA (siRNA) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Small Interfering RNA (siRNA) Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Small Interfering RNA (siRNA) Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Small Interfering RNA (siRNA) Therapeutics Consumption (2017-2022)
-
7.2 United States Small Interfering RNA (siRNA) Therapeutics Consumption (2017-2022)
-
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Consumption (2017-2022)
-
7.4 China Small Interfering RNA (siRNA) Therapeutics Consumption (2017-2022)
-
7.5 Japan Small Interfering RNA (siRNA) Therapeutics Consumption (2017-2022)
-
7.6 India Small Interfering RNA (siRNA) Therapeutics Consumption (2017-2022)
-
7.7 South Korea Small Interfering RNA (siRNA) Therapeutics Consumption (2017-2022)
8 Region and Country-wise Small Interfering RNA (siRNA) Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Small Interfering RNA (siRNA) Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Small Interfering RNA (siRNA) Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Small Interfering RNA (siRNA) Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Small Interfering RNA (siRNA) Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Small Interfering RNA (siRNA) Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Small Interfering RNA (siRNA) Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Small Interfering RNA (siRNA) Therapeutics Consumption Forecast (2022-2028)
9 Global Small Interfering RNA (siRNA) Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Small Interfering RNA (siRNA) Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)
-
9.2 Global Small Interfering RNA (siRNA) Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Application 1 Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Application 2 Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Application 3 Consumption and Growth Rate (2017-2022)
10 Global Small Interfering RNA (siRNA) Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Small Interfering RNA (siRNA) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Small Interfering RNA (siRNA) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Application 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Application 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Application 3 Consumption Forecast and Growth Rate (2022-2028)
11 Global Small Interfering RNA (siRNA) Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Small Interfering RNA (siRNA) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Small Interfering RNA (siRNA) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Small Interfering RNA (siRNA) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Small Interfering RNA (siRNA) Therapeutics Market Competitive Analysis
-
14.1 Company 1
-
14.1.1 Company 1 Company Details
-
14.1.2 Company 1 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Company 1 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.2 Company 2
-
14.2.1 Company 2 Company Details
-
14.2.2 Company 2 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Company 2 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.3 Company 3
-
14.3.1 Company 3 Company Details
-
14.3.2 Company 3 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Company 3 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.4 Company 4
-
14.4.1 Company 4 Company Details
-
14.4.2 Company 4 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Company 4 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.5 Company 5
-
14.5.1 Company 5 Company Details
-
14.5.2 Company 5 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Company 5 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.6 Company 6
-
14.6.1 Company 6 Company Details
-
14.6.2 Company 6 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Company 6 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.7 Company 7
-
14.7.1 Company 7 Company Details
-
14.7.2 Company 7 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Company 7 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.8 Company 8
-
14.8.1 Company 8 Company Details
-
14.8.2 Company 8 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Company 8 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.9 Company 9
-
14.9.1 Company 9 Company Details
-
14.9.2 Company 9 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Company 9 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
14.10 Company 10
-
14.10.1 Company 10 Company Details
-
14.10.2 Company 10 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Company 10 Small Interfering RNA (siRNA) Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Small Interfering RNA (siRNA) Therapeutics
-
Figure Small Interfering RNA (siRNA) Therapeutics Picture
-
Table Global Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Small Interfering RNA (siRNA) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Small Interfering RNA (siRNA) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Small Interfering RNA (siRNA) Therapeutics Consumption by Country (2017-2022)
-
Figure United States Small Interfering RNA (siRNA) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Small Interfering RNA (siRNA) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Small Interfering RNA (siRNA) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Small Interfering RNA (siRNA) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Small Interfering RNA (siRNA) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Small Interfering RNA (siRNA) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Small Interfering RNA (siRNA) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Small Interfering RNA (siRNA) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Small Interfering RNA (siRNA) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Small Interfering RNA (siRNA) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Small Interfering RNA (siRNA) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Small Interfering RNA (siRNA) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Small Interfering RNA (siRNA) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Application 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Application 3 Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Small Interfering RNA (siRNA) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Small Interfering RNA (siRNA) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Company 1 (Foundation Year, Company Profile and etc.)
-
Table Company 1 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 1 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 2 (Foundation Year, Company Profile and etc.)
-
Table Company 2 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 2 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 3 (Foundation Year, Company Profile and etc.)
-
Table Company 3 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 3 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 4 (Foundation Year, Company Profile and etc.)
-
Table Company 4 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 4 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 5 (Foundation Year, Company Profile and etc.)
-
Table Company 5 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 5 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 6 (Foundation Year, Company Profile and etc.)
-
Table Company 6 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 6 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 7 (Foundation Year, Company Profile and etc.)
-
Table Company 7 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 7 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 8 (Foundation Year, Company Profile and etc.)
-
Table Company 8 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 8 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 9 (Foundation Year, Company Profile and etc.)
-
Table Company 9 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 9 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
Table Company 10 (Foundation Year, Company Profile and etc.)
-
Table Company 10 Small Interfering RNA (siRNA) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Company 10 Small Interfering RNA (siRNA) Therapeutics Product and Service
-
